<SEC-DOCUMENT>0001513162-19-000198.txt : 20190904
<SEC-HEADER>0001513162-19-000198.hdr.sgml : 20190904
<ACCEPTANCE-DATETIME>20190904081918
ACCESSION NUMBER:		0001513162-19-000198
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20190904
ITEM INFORMATION:		Other Events
FILED AS OF DATE:		20190904
DATE AS OF CHANGE:		20190904

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIOMERICA INC
		CENTRAL INDEX KEY:			0000073290
		STANDARD INDUSTRIAL CLASSIFICATION:	DENTAL EQUIPMENT & SUPPLIES [3843]
		IRS NUMBER:				952645573
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0531

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37863
		FILM NUMBER:		191073344

	BUSINESS ADDRESS:	
		STREET 1:		17571 VON KARMAN AVENUE
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92614
		BUSINESS PHONE:		9496452111

	MAIL ADDRESS:	
		STREET 1:		17571 VON KARMAN AVENUE
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92614

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NMS PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	19871130

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NUCLEAR MEDICAL SYSTEMS INC
		DATE OF NAME CHANGE:	19830216

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NUCLEAR INSTRUMENTS INC
		DATE OF NAME CHANGE:	19720508
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML>
<head><title>Form 8-K</title> </head> <body style="FONT-SIZE:10pt; FONT-FAMILY:'Times New Roman'; MARGIN-TOP:0px; COLOR:#000000"> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center>SECURITIES AND EXCHANGE COMMISSION</p> <p style=MARGIN:0px><br></p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center>WASHINGTON, D.C.</p> <p style=MARGIN:0px><br></p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center>FORM 8-K</p> <p style=MARGIN:0px><br></p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center>CURRENT REPORT</p> <p style=MARGIN:0px><br></p> <p style=MARGIN:0px><br></p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center>Pursuant to Section 13 or 15(d) of the</p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center>Securities Exchange Act of 1934</p> <p style=MARGIN:0px><br></p> <p style=MARGIN:0px><br></p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center><u>_ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;September 4, 2019</u>____</p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center>Date of Report (date of earliest event reported)</p> <p style=MARGIN:0px align=center><br></p> <p style=MARGIN:0px align=center><br></p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center><u>BIOMERICA, INC.</u></p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center>(Exact Name of Registrant as Specified in its Charter)</p> <p style=MARGIN:0px><br><br> <table bordercolor=transparent cellspacing=0 align=center> <tr> <td><u>Delaware</u></td> <td>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <td> <p align=center><u>0-8765</u></p></td> <td>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <td><u>95-2645573</u></td></tr> <tr> <td>(State or Other</td> <td> <td>(Commission</td> <td> <td> <p style="FONT-SIZE:12pt; MARGIN:0px; TEXT-INDENT:-2px">(IRS Employer</p></td></tr> <tr> <td>Jurisdiction of</td> <td> <td>File Number)</td> <td> <td>Identification Number)</td></tr> <tr> <td>Incorporation)</td> <td> <td> <td> <td /></tr></table></p> <p style=MARGIN:0px align=center><br></p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center>17571 Von Karman Ave.</p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center><u>Irvine, California 92614</u></p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center>(Address of Principal Executive Offices</p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center>Including Zip Code)</p> <p style=MARGIN:0px align=center><br></p> <p style=MARGIN:0px align=center><br></p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center><u>949-645-2111</u></p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center>(Registrant&#146;s Telephone Number,</p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center>Including Area Code)</p> <p style=MARGIN:0px align=center><br></p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center>______________</p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center>(Former Name or Former Address if Changed</p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center>Since Last Report)</p> <p style=MARGIN:0px align=center><br></p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center>Page 1 of 2 pages</p> <p style=MARGIN:0px align=center><br></p> <p style=MARGIN:0px align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"> </DIV> <br> <p /> <p style=MARGIN:0px align=center><br></p> <p style=MARGIN:0px align=center><br></p> <p style=MARGIN:0px align=center><br></p> <p style="FONT-SIZE:12pt; MARGIN:0px"><b>Item 8.01 &nbsp;Other Events</b></p> <p style=MARGIN:0px><br></p> <p style="FONT-SIZE:12pt; MARGIN:0px">On May 29, 2019 (the &#147;Execution Date&#148;), Biomerica executed an exclusive distribution agreement with MaxHealth International Ltd. and MaxHealth Medical Co. Ltd. (together &#147;Maxhealth&#148;), for the sale of Biomerica&#146;s EZ Detect product in China. In the Agreement, MaxHealth was given an option to purchase 500,000 shares of Biomerica common shares for a period of 90 days following the Execution Date (the &#147;Option Period&#148;) at a purchase price of either a) $4.66 per share if during the Option Period Biomerica in a separate private transaction sells $1,000,000 of shares at a price greater than $4.66 per share, or b) 25% above the average public trading price of Biomerica&#146;s common stock during the 10 business days preceding the MaxHealth&#146;s exercise of the option and purchase of the shares. The shares must be purchased in a single transaction and must be prepaid prior to issuance. </p> <p style=MARGIN:0px><br></p> <p style="FONT-SIZE:12pt; MARGIN:0px">At the request of MaxHealth, Biomerica has executed an amendment to the Agreement that extends the Option Period to 180 days following the Execution Date. All other terms of the option and Agreement remain the same. &nbsp;</p> <p style=MARGIN:0px><br></p><a name=s9B1D8344AA2ED028FBF5BF856A071139> <p style="FONT-SIZE:12pt; MARGIN:0px">Also pertaining to this Agreement, the Company shipped an initial prepaid order of EZ Detect product to MaxHealth on August 30, 2019. Once this initial order clears customs in China, the Agreement requires MaxHealth to prepay an additional amount of $900,000 for future orders of the EZ Detect product.</p> <p style=MARGIN:0px align=justify><br></p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=justify>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br></p> <p style=MARGIN:0px><br></p> <p style=MARGIN:0px align=center><br></p> <p style=MARGIN:0px><br></p> <p style=MARGIN:0px align=center><br></p> <p style="FONT-SIZE:12pt; MARGIN:0px; PADDING-RIGHT:28px" align=center><u>SIGNATURES</u></p> <p style=MARGIN:0px><br></p> <p style="FONT-SIZE:12pt; MARGIN:0px; PADDING-RIGHT:28px">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p> <p style=MARGIN:0px><br></p> <p style="FONT-SIZE:12pt; MARGIN-BOTTOM:-2px; WIDTH:288px; MARGIN-TOP:0px; FLOAT:left">Dated: &nbsp;September 4, 2019</p> <p style="FONT-SIZE:12pt; MARGIN:0px; PADDING-RIGHT:28px; TEXT-INDENT:-2px">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Biomerica, Inc.</p> <p style="CLEAR:left; MARGIN:0px"><br></p> <p style="FONT-SIZE:12pt; MARGIN:0px; PADDING-RIGHT:28px; TEXT-INDENT:336px">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;By: <u>/s/ Zackary S. Irani</u></p> <p style="FONT-SIZE:12pt; MARGIN:0px; PADDING-RIGHT:28px; TEXT-INDENT:384px">Zackary S. Irani</p> <p style="FONT-SIZE:12pt; MARGIN:0px; PADDING-RIGHT:28px; TEXT-INDENT:384px">Chief Executive Officer</p> <p style=MARGIN:0px align=center><br></p> <p style=MARGIN:0px align=center><br></p> <p style=MARGIN:0px align=center><br><br></p></a></body>
<!-- EDGAR Validation Code: 89A1579D -->
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
